(Q411188)

Aripiprazole (English)

3 October 2016

chemical formula

C₂₃H₂₇Cl₂N₃O₂

1 reference

Aripiprazole (English)

19 November 2016

canonical SMILES

C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl

1 reference

Aripiprazole (English)

19 November 2016

defined daily dose

15 milligram

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AX12

15 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AX12

13.3 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AX12

active ingredient in

Abilify Maintena

1 reference

EMEA/H/C/002755

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002755/human_med_001711.jsp

22 March 2017

1 reference

14 February 2018

1 reference

EMEA/H/C/004021

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004021/human_med_001920.jsp

Aripiprazole Mylan Pharma

22 March 2017

1 reference

EMEA/H/C/003803

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003803/human_med_001867.jsp

22 March 2017

Aripiprazole Sandoz

1 reference

EMEA/H/C/004008

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004008/human_med_001892.jsp

22 March 2017

Aripiprazole Zentiva

1 reference

EMEA/H/C/003899

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003899/human_med_001868.jsp

World Health Organisation international non-proprietary name

22 March 2017

aripiprazole (English)

1 reference

aripiprazole (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

2 October 2018

dementia

1 reference

2 October 2018

personality disorder

1 reference

2 October 2018

Alzheimer's disease

1 reference

2 October 2018

mood disorder

1 reference

2 October 2018

mental disorder

1 reference

2 October 2018

psychosis

1 reference

obsessive-compulsive disorder

2 October 2018

1 reference

post-traumatic stress disorder

2 October 2018

1 reference

2 October 2018

anxiety

1 reference

borderline personality disorder

2 October 2018

1 reference

2 October 2018

schizoaffective disorder

1 reference

significant drug interaction

2 October 2018

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-asenapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-asenapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosphenytoin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

5-hydroxytryptamine receptor 1A

1 reference

5-hydroxytryptamine receptor 1B

17 August 2016

1 reference

5-hydroxytryptamine receptor 1D

17 August 2016

1 reference

5-hydroxytryptamine receptor 2A

17 August 2016

1 reference

5-hydroxytryptamine receptor 2C

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

Histamine receptor H1

1 reference

17 August 2016

legal status (medicine)

boxed warning

applies to jurisdiction

United States of America

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category B3

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Aripiprazole

20 July 2017

1 reference

Medical Subject Headings

MeSH descriptor ID

D000068180

Institute for Safe Medication Practices

15 March 2018

atypical antipsychotic

0 references

ARIPiprazole

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

2 September 2022

0 references

0 references

0 references

0 references

Aripiprazole

0 references

Identifiers

NL CR AUT ID

ph1046638

subject named as

aripiprazol

0 references

InChI

InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)

1 reference

Aripiprazole (English)

19 November 2016

2 references

Aripiprazole (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

129722-12-9

2 references

aripiprazole (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=129722-12-9

10 April 2021

1 reference

Aripiprazole (English)

19 November 2016

2 references

Aripiprazole (English)

19 November 2016

ChEBI ID

31236

mapping relation type

2 references

ARIPIPRAZOLE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)

1 reference

ARIPIPRAZOLE (English)

19 November 2016

2 references

inferred from InChIKey

Hazardous Substances Data Bank

1 reference

1 reference

28 October 2019

ARIPIPRAZOLE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.112.532

27 December 2018

ECHA Substance Infocard ID

7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one (English)

quotation

CAS no.: 129722-12-9 (English)

100.112.532

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.112.532

27 December 2018

7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one (English)

quotation

CAS no.: 129722-12-9 (English)

1 reference

Aripiprazole (English)

publication date

17 November 2015

1 reference

aripiprazole (English)

19 November 2016

Aripiprazole

0 references

0 references

0 references

D03.633.100.810.835.122

0 references

RxNorm ID

89013

1 reference

aripiprazole (English)

19 November 2016

DrugBank ID

DB01238

1 reference

Human Metabolome Database ID

HMDB0005042

2 references

based on heuristic

inferred from InChIKey

2 references

aripiprazole (English)

19 November 2016

MedlinePlus drug identifier

a603012

oral administration

0 references

a615048

PatientsLikeMe treatment ID

intramuscular injection

0 references

0 references

1 reference

aripiprazole (English)

19 November 2016

0 references

1 reference

1 reference

aripiprazole (English)

3 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

aripiprazole (English)

3 October 2016

0 references

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

1 reference

UK Parliament thesaurus ID

510574

subject named as

Aripiprazole

0 references

UMLS CUI

C0299792

1 reference

aripiprazole (English)